179 related articles for article (PubMed ID: 27755229)
21. High-risk human papillomaviruses distribution in Romanian women with negative cytology.
Plesa A; Socolov D; Huica I; Botezatu A; Iancu IV; Ungureanu C; Teleman S; Albulescu A; Fudulu A; Anton G
J Infect Dev Ctries; 2019 Apr; 13(4):326-333. PubMed ID: 32045377
[TBL] [Abstract][Full Text] [Related]
22. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
[TBL] [Abstract][Full Text] [Related]
23. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
[TBL] [Abstract][Full Text] [Related]
24. Oral Human Papillomavirus in Women With High-Grade Cervical Intraepithelial Neoplasia.
Woelber L; Breuer J; Meyer T; Vettorazzi E; Prieske K; Bohlmann I; Busch CJ; Teudt I; Brummer O; Mueller V; Schmalfeldt B; Grimm D
J Low Genit Tract Dis; 2017 Jul; 21(3):177-183. PubMed ID: 28481782
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus prevalence and genotype distribution among Turkish women with or without cervical lesion.
Demirci M; Guzel AD; Ersahin AA; Yorulmaz E; Ersahin SS; Borsa BA
Indian J Med Microbiol; 2018; 36(4):517-521. PubMed ID: 30880699
[TBL] [Abstract][Full Text] [Related]
26. Changes in human papillomavirus genotypes associated with cervical intraepithelial neoplasia grade 2 lesions in a cohort of young women (2013-2016).
Innes CR; Sykes PH; Harker D; Williman JA; Van der Griend RA; Whitehead M; Hibma M; Lawton BA; Fitzgerald P; Dudley NM; Petrich S; Faherty J; Bergzoll C; Eva L; Sadler L; Simcock BJ
Papillomavirus Res; 2018 Dec; 6():77-82. PubMed ID: 30391363
[TBL] [Abstract][Full Text] [Related]
27. Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women.
Kitchener H; Nelson L; Adams J; Mesher D; Sasieni P; Cubie H; Moore C; Heard I; Agarossi A; Casolati E; Denny L; Bradbeer C; Lyons F; Beattie G; Niemiec T
Int J Cancer; 2007 Dec; 121(11):2484-91. PubMed ID: 17683070
[TBL] [Abstract][Full Text] [Related]
28. The importance of low-risk HPV infection for the risk of abnormal cervical cytology/histology in more than 40 000 Danish women.
Nielsen A; Iftner T; Nørgaard M; Munk C; Junge J; Kjaer SK
Sex Transm Infect; 2012 Dec; 88(8):627-32. PubMed ID: 22773328
[TBL] [Abstract][Full Text] [Related]
29. The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China.
Zhang HY; Fei MD; Jiang Y; Fei QY; Qian H; Xu L; Jin YN; Jiang CQ; Li HX; Tiggelaar SM; Smith JS; Sahasrabuddhe VV; Qiao YL
Virol J; 2014 Dec; 11():202. PubMed ID: 25481842
[TBL] [Abstract][Full Text] [Related]
30. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.
Vrdoljak-Mozetič D; Krašević M; Verša Ostojić D; Štemberger-Papić S; Rubeša-Mihaljević R; Bubonja-Šonje M
Cytopathology; 2015 Feb; 26(1):10-8. PubMed ID: 24261348
[TBL] [Abstract][Full Text] [Related]
31. Analysis of risk factors for persistent infection of asymptomatic women with high-risk human papilloma virus.
Shi N; Lu Q; Zhang J; Li L; Zhang J; Zhang F; Dong Y; Zhang X; Zhang Z; Gao W
Hum Vaccin Immunother; 2017 Jun; 13(6):1-7. PubMed ID: 28409676
[TBL] [Abstract][Full Text] [Related]
32. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus prevalence and genotypes distribution among female outpatients in Qingdao, East China.
Bi Q; Zhang L; Zhao Z; Mu X; Zhang M; Wang P
J Med Virol; 2015 Dec; 87(12):2114-21. PubMed ID: 26069229
[TBL] [Abstract][Full Text] [Related]
34. Risk of cervical HPV infection and prevalence of vaccine-type and other high-risk HPV types among sexually active teens and young women (13-26 years) enrolled in the VALHIDATE study.
Orlando G; Fasolo M; Mazza F; Ricci E; Esposito S; Frati E; Zuccotti GV; Cetin I; Gramegna M; Rizzardini G; Tanzi E;
Hum Vaccin Immunother; 2014; 10(4):986-94. PubMed ID: 24423757
[TBL] [Abstract][Full Text] [Related]
35. Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.
Woestenberg PJ; King AJ; van Benthem BHB; Donken R; Leussink S; van der Klis FRM; de Melker HE; van der Sande MAB; Hoebe CJPA; Bogaards JA;
J Infect Dis; 2018 Jan; 217(2):213-222. PubMed ID: 29140439
[TBL] [Abstract][Full Text] [Related]
36. Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
McGregor S; Saulo D; Brotherton JML; Liu B; Phillips S; Skinner SR; Luey M; Oliver L; Stewart M; Tabrizi SN; Garland S; Kaldor JM
Vaccine; 2018 Jul; 36(29):4311-4316. PubMed ID: 29880245
[TBL] [Abstract][Full Text] [Related]
37. Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria.
Borena W; Grünberger M; Widschwendter A; Kraxner KH; Marth E; Mayr P; Meier J; Ruth N; Guerrero AT; Marth C; Holm-von Laer D
BMC Public Health; 2016 Aug; 16(1):889. PubMed ID: 27565569
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of Primary HPV in Djibouti: Feasibility of Screening for Early Diagnosis of Squamous Intraepithelial Lesions.
Petrelli A; Di Napoli A; Giorgi Rossi P; Rossi A; Luccini D; Di Marco I; Traoré AL; Gillio Tos A; Trevisan M; Mirisola C; Costanzo G
J Low Genit Tract Dis; 2016 Oct; 20(4):321-6. PubMed ID: 27467824
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Human Papillomavirus infection among Chilean women from 2012 to 2016.
Vergara N; Espinoza G; Balanda M; Quiero A; Hidalgo W; San Martín H; Ramírez A; Ramírez E
J Med Virol; 2017 Sep; 89(9):1646-1653. PubMed ID: 28294358
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus (HPV) prevalence and associated risk factors in women from Curaçao.
Hooi DJ; Lissenberg-Witte BI; Kenter G; de Koning MNC; Gomes Bravio I; Ardts K; Kleinmoedig S; Benita E; Pinedo HM; Berkhof J; Quint WGV; Meijer CJLM
PLoS One; 2018; 13(7):e0199624. PubMed ID: 30005066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
